MedTechIQ_3Helix InSight Engine-Beta
Preview
Open in TheBrain
Triple Helix Discovery Engine
Watch List: Bankruptcy Filing, Financial Collapse
PhaseBio Pharmaceuticals, Inc. (Nasdaq: PHAS)
Finance & Acquisitions: PhaseBio
Parents
PhaseBio Pharmaceuticals, Inc. (Nasdaq: PHAS)
Children
2010: PhaseBio Pharma Adds $15M in Series B Financing (2010)
2023: PhaseBio Plans for Near-Term Sale Using Structured Process Through Chapter 11 of U.S. Bankruptcy Code
The additional $15 million comes as PhaseBio begins testing its drug Glymera, a biopolymer that increases the impact of certain drugs so it cuts the amounts (and cost) needed.
Will file in 2011 a second investigational new drug application for Vasomera, which treats hypertension.
Jumps
*Key People: PhaseBio
Organization & Developments: PhaseBio